The State of Diabetes Prevention Policy in the USA Following the Affordable Care Act

Juleigh Nowinski Konchak, Margaret R. Moran, Matthew J. O’Brien, Namratha R. Kandula, Ronald T. Ackermann*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Type 2 diabetes is a major public health problem in the USA, affecting over 12 % of American adults and imposing considerable health and economic burden on individuals and society. There is a strong evidence base demonstrating that lifestyle behavioral changes and some medications can prevent or delay the onset of type 2 diabetes in high risk adults, and several policy and healthcare system changes motivated by the Patient Protection and Affordable Care Act (ACA) have the potential to accelerate diabetes prevention. In this narrative review, we (1) offer a conceptual framework for organizing how the ACA may influence diabetes prevention efforts at the level of individuals, healthcare providers, and health systems; (2) highlight ACA provisions at each of these levels that could accelerate type 2 diabetes prevention nationwide; and (3) explore possible policy gaps and opportunity areas for future research and action.

Original languageEnglish (US)
Article number55
JournalCurrent diabetes reports
Issue number6
StatePublished - Jun 1 2016


  • Affordable Care Act
  • Diabetes
  • Health policy
  • Prediabetes
  • Primary prevention

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'The State of Diabetes Prevention Policy in the USA Following the Affordable Care Act'. Together they form a unique fingerprint.

Cite this